IMMUNOTHERAPY-NAIVE

Clinical trials for IMMUNOTHERAPY-NAIVE explained in plain language.

Never miss a new study

Get alerted when new IMMUNOTHERAPY-NAIVE trials appear

Sign up with your email to follow new studies for IMMUNOTHERAPY-NAIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New attack on deadly pancreatic cancer spread

Disease control Not yet recruiting

This study is testing a new combination treatment for people with pancreatic cancer that has spread to the liver and who have not had prior treatment. The approach delivers chemotherapy directly to the liver tumors and combines it with two immunotherapy drugs. The main goal is to…

Matched conditions: IMMUNOTHERAPY-NAIVE

Phase: PHASE2 • Sponsor: Shandong Provincial Hospital • Aim: Disease control

Last updated Mar 10, 2026 12:54 UTC

IMMUNOTHERAPY-NAIVE

Get alerted when new IMMUNOTHERAPY-NAIVE trials appear

New attack on deadly pancreatic cancer spread